Faculty Opinions recommendation of Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.723494560.793514264 ◽

2016 ◽

Author(s):

Badrinath Konety

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Adjuvant Radiotherapy ◽

Advanced Prostate Cancer

Get full-text (via PubEx)

Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer: A Randomized Clinical Trial

Yearbook of Urology ◽

10.1016/s0084-4071(08)70143-x ◽

2007 ◽

Vol 2007 ◽

pp. 180-182

Author(s):

A.S. Kibel ◽

G.L. Andriole

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Adjuvant Radiotherapy ◽

Advanced Prostate Cancer

Get full-text (via PubEx)

ADJUVANT RADIOTHERAPY FOR PATHOLOGICALLY ADVANCED PROSTATE CANCER: META-ANALYSES OF RANDOMIZED CLINICAL TRIAL

The Journal of Urology ◽

10.1016/s0022-5347(08)60532-7 ◽

2008 ◽

Vol 179 (4S) ◽

pp. 183-184 ◽

Cited By ~ 4

Author(s):

Matheus T Roque ◽

Minori Saito ◽

Auro AS De Souza ◽

Gustavo A Viani ◽

Eduardo J Stefano ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Adjuvant Radiotherapy ◽

Advanced Prostate Cancer ◽

Meta Analyses

Get full-text (via PubEx)

Faculty Opinions recommendation of Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1157429.617587 ◽

2009 ◽

Author(s):

George Huang

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Adjuvant Radiotherapy

Get full-text (via PubEx)

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

Yearbook of Urology ◽

10.1016/s0084-4071(09)79264-4 ◽

2009 ◽

Vol 2009 ◽

pp. 126-127

Author(s):

A.S. Kibel

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Adjuvant Radiotherapy

Get full-text (via PubEx)

A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)

European Journal of Cancer ◽

10.1016/j.ejca.2021.08.032 ◽

2021 ◽

Vol 158 ◽

pp. 63-71

Author(s):

Fernando C. Maluf ◽

Fabio A. Schutz ◽

Eduardo H. Cronemberger ◽

Murilo de A. Luz ◽

Suelen P.S. Martins ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Advanced Prostate Cancer ◽

Phase 2 ◽

Testosterone Levels

Get full-text (via PubEx)

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

The Journal of Urology ◽

10.1016/j.juro.2008.11.032 ◽

2009 ◽

Vol 181 (3) ◽

pp. 956-962 ◽

Cited By ~ 820

Author(s):

Ian M. Thompson ◽

Catherine M. Tangen ◽

Jorge Paradelo ◽

M. Scott Lucia ◽

Gary Miller ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Adjuvant Radiotherapy

Get full-text (via PubEx)

Re: Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

The Journal of Urology ◽

10.1016/j.juro.2009.07.053 ◽

2009 ◽

Vol 182 (5) ◽

pp. 2531-2534 ◽

Cited By ~ 4

Author(s):

Tina Cheng ◽

Daniel Y. Heng ◽

Douglas Stewart

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Adjuvant Radiotherapy

Get full-text (via PubEx)

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

Yearbook of Medicine ◽

10.1016/s0084-3873(10)79868-0 ◽

2010 ◽

Vol 2010 ◽

pp. 151-152

Author(s):

C.A. Lawton

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Adjuvant Radiotherapy

Get full-text (via PubEx)

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

Yearbook of Oncology ◽

10.1016/s1040-1741(09)79425-4 ◽

2010 ◽

Vol 2010 ◽

pp. 78-79

Author(s):

C.A. Lawton

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Adjuvant Radiotherapy

Get full-text (via PubEx)

Commentary on Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term follow-up of a randomized clinical trial

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2009.04.016 ◽

2009 ◽

Vol 27 (4) ◽

pp. 456-457 ◽

Cited By ~ 1

Author(s):

Mark A. Ritter

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Adjuvant Radiotherapy ◽

Long Term Follow Up

Get full-text (via PubEx)